Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial
    Published on 2025-05-17
    2 months ago
  • Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
    Published on 2025-05-15
    2 months ago
  • Selective KOR antagonist alters functional patch sizes in individualized brain system: results from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
    Published on 2025-05-13
    2 months ago
  • Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of synaptic pruning
    Published on 2025-05-09
    2 months ago
  • Demand for heroin in rats: effects of non-drug alternative substitutes and complements
    Published on 2025-05-09
    2 months ago
  • Posttraining noradrenergic stimulation maintains hippocampal engram reactivation and episodic-like specificity of remote memory
    Published on 2025-05-08
    2 months ago
  • Antipsychotics cause reversible structural brain changes within one week
    Published on 2025-05-07
    2 months ago
« Previous 1 … 4 5 6 7 8 … 143 Next »
Journal of Psychopharmacology
  • Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
    Published on 2025-05-06
    2 months ago
  • Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?
    Published on 2025-05-05
    2 months ago
  • Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
    Published on 2025-05-05
    2 months ago
  • Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program
    Published on 2025-04-26
    2 months ago
  • Therapeutic effects of resveratrol on memory deficits in offspring of sleep-deprived rats: Involvement of hippocampal BDNF-TrkB pathways
    Published on 2025-04-24
    2 months ago
  • Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
    Published on 2025-04-21
    3 months ago
  • Daily supplementation with lemon verbena extract decreases subjective energy and parental reports of hyperactivity in children displaying sub-clinical attention deficit hyperactivity disorder-type behaviours: A randomised controlled trial
    Published on 2025-04-19
    3 months ago
« Previous 1 … 4 5 6 7 8 … 123 Next »
European Neuropsychopharmacology
  • Frequency, correlates and outcomes of Benzodiazepine use during Cariprazine treatment: A pooled post-hoc analysis from four 6-week, placebo-controlled trials in patients with an acute exacerbation of schizophrenia
    Published on 2025-03-16
    4 months ago
  • Letter to the editor: Premature conclusions on antipsychotic continuation in environmentally conscious psychopharmacotherapy
    Published on 2025-03-13
    4 months ago
  • COSMIN systematic review and meta-analysis of the measurement properties of the PANSS-6
    Published on 2025-03-10
    4 months ago
  • Ketamine addiction in Europe: Any risks on the horizons?
    Published on 2025-03-10
    4 months ago
  • Preclinical drug development: Seeking to improve the reproducibility of results from behavioural experiments in animals
    Published on 2025-03-09
    4 months ago
  • Muscarinic acetylcholine receptor agonists in bipolar disorder
    Published on 2025-03-09
    4 months ago
  • Extracellular vesicles in mood disorders: A systematic review of human studies
    Published on 2025-03-09
    4 months ago
« Previous 1 … 4 5 6 7 8 … 144 Next »

   Pharma Pub